Chronic Kidney Disease Stage 5 m6A RNA Modification Microarray Data

Zhiqian Yang published microarray data profiling N6-methyladenosine (m6A) modifications on small RNAs in patients with Chronic Kidney Disease stage 5. The 44.2 MB dataset includes files in PDF, JPG, XLSX, and TXT formats. It was last updated on April 3, 2026.

Use Cases

• Identify differentially methylated small RNA features between CKD stage 5 and control samples using microarray intensity values.
• Build a regulatory network linking m6A-modified miRNAs to known CKD pathways using the provided network data.
• Validate m6A modification patterns from the XLSX files with independent sequencing datasets.

Strengths

• Dataset focuses on the clinically severe CKD stage 5, a specific disease state.
• Includes multiple file formats (XLSX, TXT, PDF) providing raw data and analysis reports.
• Released under the permissive Apache-2.0 license for wide reuse.

Limitations

• Small dataset size of 44.2 MB suggests a limited sample or feature count.
• Unknown row count and specific column structure hinders immediate assessment of statistical power.
• Platform tags indicate data may be derived from a single microarray technology (Arraystar).

Provenance

Source

Zhiqian Yang via figshare.

Collection Method

Generated using Arraystar Human m6A smallRNA Epi-Report microarray technology.

Freshness

Last updated in April 2026.